Renalytix AI GAAP EPS of -$0.05, revenue of $1.25M; reaffirms outlook
Source: SeekingAlpha
2025-03-18 08:15:37 ET
More on Renalytix Plc, Renalytix AI, etc.
Read the full article on Seeking Alpha
For further details see:
Renalytix AI GAAP EPS of -$0.05, revenue of $1.25M; reaffirms outlook
Renalytix plc
NASDAQ: RNLXY
RNLXY Trading
-8.09% G/L:
$2.16 Last:
2,324 Volume:
$2.25 Open:
RNLXY Latest News
November 18, 2025 07:51:00 am
Pivotal kidneyintelX.dkd Data Published in Diabetes Care, Considered the Leading Clinical Journal Worldwide in Diabetes
September 15, 2025 08:00:00 am
Renalytix Announces Collaboration with Tempus to Advance Intelligent Risk Assessment in Diabetic Kidney Disease
July 21, 2025 07:00:00 am
MVP Health Care and Renalytix Partner to Bring Life-Changing Kidney Disease Testing to Local Communities
RNLXY Stock Data
$34,786,689
8,652,970
19.74%
3
378915%
Healthcare Providers & Services
Healthcare
GB
London
